Showing results (841-850 of 1,206) with videos related to

Sort By:
Pageof 121
Circulation. Cardiovascular Interventions|May 22, 2014
Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction: two-year clinical results of the COMFORTABLE AMI trialLorenz Räber, Henning Kelbæk, Masanori Taniwaki, et al.
Circulation Reports|August 12, 2024
One-Month Dual Antiplatelet Therapy in High Bleeding Risk Asian Patients Undergoing Percutaneous Coronary Intervention - Onyx ONE Clear 2-Year ResultsJeehoon Kang, Abdul Kahar Abdul Ghapar, Kamaraj Selvaraj, et al.
JACC. Cardiovascular Interventions|February 12, 2025
Transapical Transcatheter Mitral Valve Replacement After Failed Transcatheter Edge-to-Edge Repair: A Multicenter ExperienceDaryoush Samim, Paul Sorajja, Jonas Lanz, et al.
European Heart Journal. Acute Cardiovascular Care|September 7, 2021
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trialAntonio Landi, Mattia Branca, Giuseppe Andò, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 31, 2008
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT)Emanuele Meliga, Hector M Garcia-Garcia, Marco Valgimigli, et al.
European Journal of Heart Failure|March 2, 2026
Rationale and design of a randomized, sham-controlled, clinical trial for evaluation of the Edwards APTURE transcatheter shunt system (ALT-FLOW II)Dean J Kereiakes, Ryan J Tedford, JoAnn Lindenfeld, et al.
JACC. Cardiovascular Interventions|June 25, 2025
Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 TrialsHelene Eltchaninoff, Stephan Windecker, Michael J Mack, et al.
JACC. Cardiovascular Interventions|September 26, 2009
Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudyJoanna J Wykrzykowska, Patrick W Serruys, Yoshinobu Onuma, et al.
Circulation. Cardiovascular Interventions|March 1, 2021
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting StentAjay J Kirtane, Robert Stoler, Robert Feldman, et al.
The International Journal of Cardiovascular Imaging|February 28, 2015
Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudyMasanori Taniwaki, Maria D Radu, Hector M Garcia-Garcia, et al.
Pageof 121